Hey I am on Medial • 6m
Most founders fantasize about having a “cornered resource” when the truth is, you don’t. Exclusive distribution, talent, or patents are rare unless you’re working at deeptech or pharma level. Trying to build your business around a “secret sauce” you don’t have just slows you down.
Full Stack Software ... • 1m
🚫 You don’t really need technology… unless you want to grow. ❌ You don’t need a website if you’re okay with staying invisible online. ❌ You don’t need a software if you enjoy doing repetitive work manually. ❌ You don’t need a web app if managing bo
See More"Building Brands. Cr... • 9m
Ideas Are Everywhere, Execution is Rare Everyone has ideas. Everyone dreams of building something big. But how many actually take action? The world isn’t short on ideas—it’s short on executors. You don’t need a revolutionary idea. You don’t need
See More
Transforming ideas i... • 7m
Want to know why most startups fail? The answer lies in the Valley of Value Creation. Here's what I learned about creating true value in business: • You must find the sweet spot between rare AND valuable • Building what YOU want isn't enough •
See More•
Codestam Technologies • 5m
dear fresher, you’re not “just” a fresher. you’re someone who dared to begin. and that’s rare. some tips no one gives you: – stuck in tutorials? build one small project. – afraid to apply? do it anyway. most people don’t. – don’t know everything?
See MoreHey I am on Medial • 6m
A quick short read one should must explore. Purpose: To build enduring, compounding business value ("Power" = sustainable differential advantage). Few build Power while other chase growth. #Hamilton Helmer breaks it down into 7 defensible advanta
See More

•
ADJUVA LEGAL® • 1m
Trump’s 100% Pharma Tariff: A Wake-Up Call for India’s Innovation Backbone ⚕️ On Oct 1, the US will impose a 100% tariff on branded and patented pharmaceutical imports - UNLESS companies are actively building manufacturing plants in America. India
See MoreDownload the medial app to read full posts, comements and news.